Centre directs strict vigil to enforce low prices for anti-cancer drugs

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has directed strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, for which the reduced prices came into effect from November 9, an official statement said on Friday.

The latest revised price lists,



based on submissions received from companies up to November 11, 2026, are available on the NPPA website and Pharma Sahi Daam app/portal. 

All manufacturers, retailers, dealers, stockists, hospitals and medical institutions have been directed to comply with the revised prices and prominently display the updated price lists at their premises and websites.